Policy & Medicine February 1, 2025
Welcome to this Week in Policy and Medicine. The past week has seen significant settlements, legislative initiatives, and enforcement actions that continue to shape the healthcare landscape. This Week in Policy and Medicine is available on Spotify and your favorite podcast apps. From multi-million-dollar resolutions over questionable practices to new laws aimed at transparency in drug pricing, here’s a detailed look at the latest news:
Major Settlements and Legal Actions
Pfizer Subsidiary Biohaven Settles Nearly $60 Million
In a notable enforcement action, Pfizer’s subsidiary Biohaven has agreed to a settlement of nearly $60 million following a complaint related to its speaker programs. The investigation revealed that the company had underreported significant open payments associated with these programs. This resolution underscores...
Today's Sponsors
Today's Sponsor